カテゴリー： Market Monitor Global, 世界, 医療/バイオ

ナタリズマブ薬の世界市場見通し2023年-2029年

◆英語タイトル：Natalizumab Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5798）

◆商品コード：MMG23JU5798
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：75
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Natalizumab Drug Market 調査レポートは次の情報を含め、グローバルにおけるのナタリズマブ薬市場規模と予測を収録しています。・世界のナタリズマブ薬市場：売上、2018年-2023年、2024年-2029年
・世界のナタリズマブ薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のナタリズマブ薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「多発性硬化症」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

ナタリズマブ薬のグローバル主要企業は、Biogenなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、ナタリズマブ薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のナタリズマブ薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のナタリズマブ薬市場：タイプ別市場シェア、2022年
・多発性硬化症、クローン病

世界のナタリズマブ薬市場：用途別、2018年-2023年、2024年-2029年
世界のナタリズマブ薬市場：用途別市場シェア、2022年
・病院、ドラッグストア

世界のナタリズマブ薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のナタリズマブ薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるナタリズマブ薬のグローバル売上、2018年-2023年
・主要企業におけるナタリズマブ薬のグローバル売上シェア、2022年
・主要企業におけるナタリズマブ薬のグローバル販売量、2018年-2023年
・主要企業におけるナタリズマブ薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Biogen

*************************************************************

・調査・分析レポートの概要
ナタリズマブ薬市場の定義
市場セグメント
世界のナタリズマブ薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のナタリズマブ薬市場規模
世界のナタリズマブ薬市場規模：2022年 VS 2029年
世界のナタリズマブ薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのナタリズマブ薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のナタリズマブ薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：多発性硬化症、クローン病
ナタリズマブ薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、ドラッグストア
ナタリズマブ薬の用途別グローバル売上・予測

・地域別市場分析
地域別ナタリズマブ薬市場規模 2022年と2029年
地域別ナタリズマブ薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Biogen
...

Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to severe Crohn’s disease in adults. Tysabri is usually given after other Crohn’s disease medications have been tried without successful treatment of this condition.
This report aims to provide a comprehensive presentation of the global market for Natalizumab Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natalizumab Drug. This report contains market size and forecasts of Natalizumab Drug in global, including the following market information:
Global Natalizumab Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Natalizumab Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Natalizumab Drug companies in 2022 (%)
The global Natalizumab Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Multiple Sclerosis Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Natalizumab Drug include Biogen. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Natalizumab Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Natalizumab Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Natalizumab Drug Market Segment Percentages, by Type, 2022 (%)
Multiple Sclerosis
Crohn’s Disease
Global Natalizumab Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Natalizumab Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Drugs Stores
Global Natalizumab Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Natalizumab Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Natalizumab Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Natalizumab Drug revenues share in global market, 2022 (%)
Key companies Natalizumab Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Natalizumab Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Natalizumab Drug, market overview.
Chapter 2: Global Natalizumab Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Natalizumab Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Natalizumab Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Natalizumab Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Natalizumab Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Natalizumab Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Natalizumab Drug Overall Market Size
2.1 Global Natalizumab Drug Market Size: 2022 VS 2029
2.2 Global Natalizumab Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Natalizumab Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Natalizumab Drug Players in Global Market
3.2 Top Global Natalizumab Drug Companies Ranked by Revenue
3.3 Global Natalizumab Drug Revenue by Companies
3.4 Global Natalizumab Drug Sales by Companies
3.5 Global Natalizumab Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Natalizumab Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Natalizumab Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Natalizumab Drug Players in Global Market
3.8.1 List of Global Tier 1 Natalizumab Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Natalizumab Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Natalizumab Drug Market Size Markets, 2022 & 2029
4.1.2 Multiple Sclerosis
4.1.3 Crohn’s Disease
4.2 By Type – Global Natalizumab Drug Revenue & Forecasts
4.2.1 By Type – Global Natalizumab Drug Revenue, 2018-2023
4.2.2 By Type – Global Natalizumab Drug Revenue, 2024-2029
4.2.3 By Type – Global Natalizumab Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Natalizumab Drug Sales & Forecasts
4.3.1 By Type – Global Natalizumab Drug Sales, 2018-2023
4.3.2 By Type – Global Natalizumab Drug Sales, 2024-2029
4.3.3 By Type – Global Natalizumab Drug Sales Market Share, 2018-2029
4.4 By Type – Global Natalizumab Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Natalizumab Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Drugs Stores
5.2 By Application – Global Natalizumab Drug Revenue & Forecasts
5.2.1 By Application – Global Natalizumab Drug Revenue, 2018-2023
5.2.2 By Application – Global Natalizumab Drug Revenue, 2024-2029
5.2.3 By Application – Global Natalizumab Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Natalizumab Drug Sales & Forecasts
5.3.1 By Application – Global Natalizumab Drug Sales, 2018-2023
5.3.2 By Application – Global Natalizumab Drug Sales, 2024-2029
5.3.3 By Application – Global Natalizumab Drug Sales Market Share, 2018-2029
5.4 By Application – Global Natalizumab Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Natalizumab Drug Market Size, 2022 & 2029
6.2 By Region – Global Natalizumab Drug Revenue & Forecasts
6.2.1 By Region – Global Natalizumab Drug Revenue, 2018-2023
6.2.2 By Region – Global Natalizumab Drug Revenue, 2024-2029
6.2.3 By Region – Global Natalizumab Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Natalizumab Drug Sales & Forecasts
6.3.1 By Region – Global Natalizumab Drug Sales, 2018-2023
6.3.2 By Region – Global Natalizumab Drug Sales, 2024-2029
6.3.3 By Region – Global Natalizumab Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Natalizumab Drug Revenue, 2018-2029
6.4.2 By Country – North America Natalizumab Drug Sales, 2018-2029
6.4.3 US Natalizumab Drug Market Size, 2018-2029
6.4.4 Canada Natalizumab Drug Market Size, 2018-2029
6.4.5 Mexico Natalizumab Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Natalizumab Drug Revenue, 2018-2029
6.5.2 By Country – Europe Natalizumab Drug Sales, 2018-2029
6.5.3 Germany Natalizumab Drug Market Size, 2018-2029
6.5.4 France Natalizumab Drug Market Size, 2018-2029
6.5.5 U.K. Natalizumab Drug Market Size, 2018-2029
6.5.6 Italy Natalizumab Drug Market Size, 2018-2029
6.5.7 Russia Natalizumab Drug Market Size, 2018-2029
6.5.8 Nordic Countries Natalizumab Drug Market Size, 2018-2029
6.5.9 Benelux Natalizumab Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Natalizumab Drug Revenue, 2018-2029
6.6.2 By Region – Asia Natalizumab Drug Sales, 2018-2029
6.6.3 China Natalizumab Drug Market Size, 2018-2029
6.6.4 Japan Natalizumab Drug Market Size, 2018-2029
6.6.5 South Korea Natalizumab Drug Market Size, 2018-2029
6.6.6 Southeast Asia Natalizumab Drug Market Size, 2018-2029
6.6.7 India Natalizumab Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Natalizumab Drug Revenue, 2018-2029
6.7.2 By Country – South America Natalizumab Drug Sales, 2018-2029
6.7.3 Brazil Natalizumab Drug Market Size, 2018-2029
6.7.4 Argentina Natalizumab Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Natalizumab Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Natalizumab Drug Sales, 2018-2029
6.8.3 Turkey Natalizumab Drug Market Size, 2018-2029
6.8.4 Israel Natalizumab Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Natalizumab Drug Market Size, 2018-2029
6.8.6 UAE Natalizumab Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Biogen
7.1.1 Biogen Company Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Natalizumab Drug Major Product Offerings
7.1.4 Biogen Natalizumab Drug Sales and Revenue in Global (2018-2023)
7.1.5 Biogen Key News & Latest Developments
8 Global Natalizumab Drug Production Capacity, Analysis
8.1 Global Natalizumab Drug Production Capacity, 2018-2029
8.2 Natalizumab Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Natalizumab Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Natalizumab Drug Supply Chain Analysis
10.1 Natalizumab Drug Industry Value Chain
10.2 Natalizumab Drug Upstream Market
10.3 Natalizumab Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Natalizumab Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Natalizumab Drug in Global Market
Table 2. Top Natalizumab Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Natalizumab Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Natalizumab Drug Revenue Share by Companies, 2018-2023
Table 5. Global Natalizumab Drug Sales by Companies, (K Units), 2018-2023
Table 6. Global Natalizumab Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Natalizumab Drug Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Natalizumab Drug Product Type
Table 9. List of Global Tier 1 Natalizumab Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Natalizumab Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Natalizumab Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Natalizumab Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Natalizumab Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Natalizumab Drug Sales (K Units), 2018-2023
Table 15. By Type - Global Natalizumab Drug Sales (K Units), 2024-2029
Table 16. By Application – Global Natalizumab Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Natalizumab Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Natalizumab Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Natalizumab Drug Sales (K Units), 2018-2023
Table 20. By Application - Global Natalizumab Drug Sales (K Units), 2024-2029
Table 21. By Region – Global Natalizumab Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Natalizumab Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Natalizumab Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Natalizumab Drug Sales (K Units), 2018-2023
Table 25. By Region - Global Natalizumab Drug Sales (K Units), 2024-2029
Table 26. By Country - North America Natalizumab Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Natalizumab Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Natalizumab Drug Sales, (K Units), 2018-2023
Table 29. By Country - North America Natalizumab Drug Sales, (K Units), 2024-2029
Table 30. By Country - Europe Natalizumab Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Natalizumab Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Natalizumab Drug Sales, (K Units), 2018-2023
Table 33. By Country - Europe Natalizumab Drug Sales, (K Units), 2024-2029
Table 34. By Region - Asia Natalizumab Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Natalizumab Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Natalizumab Drug Sales, (K Units), 2018-2023
Table 37. By Region - Asia Natalizumab Drug Sales, (K Units), 2024-2029
Table 38. By Country - South America Natalizumab Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Natalizumab Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Natalizumab Drug Sales, (K Units), 2018-2023
Table 41. By Country - South America Natalizumab Drug Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Natalizumab Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Natalizumab Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Natalizumab Drug Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Natalizumab Drug Sales, (K Units), 2024-2029
Table 46. Biogen Company Summary
Table 47. Biogen Natalizumab Drug Product Offerings
Table 48. Biogen Natalizumab Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Biogen Key News & Latest Developments
Table 50. Natalizumab Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 51. Global Natalizumab Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global Natalizumab Drug Production by Region, 2018-2023 (K Units)
Table 53. Global Natalizumab Drug Production by Region, 2024-2029 (K Units)
Table 54. Natalizumab Drug Market Opportunities & Trends in Global Market
Table 55. Natalizumab Drug Market Drivers in Global Market
Table 56. Natalizumab Drug Market Restraints in Global Market
Table 57. Natalizumab Drug Raw Materials
Table 58. Natalizumab Drug Raw Materials Suppliers in Global Market
Table 59. Typical Natalizumab Drug Downstream
Table 60. Natalizumab Drug Downstream Clients in Global Market
Table 61. Natalizumab Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Natalizumab Drug Segment by Type in 2022
Figure 2. Natalizumab Drug Segment by Application in 2022
Figure 3. Global Natalizumab Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Natalizumab Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Natalizumab Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Natalizumab Drug Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Natalizumab Drug Revenue in 2022
Figure 9. By Type - Global Natalizumab Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Natalizumab Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Natalizumab Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Natalizumab Drug Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Natalizumab Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Natalizumab Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Natalizumab Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Natalizumab Drug Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Natalizumab Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Natalizumab Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Natalizumab Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Natalizumab Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Natalizumab Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Natalizumab Drug Sales Market Share, 2018-2029
Figure 23. US Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Natalizumab Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Natalizumab Drug Sales Market Share, 2018-2029
Figure 28. Germany Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Natalizumab Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Natalizumab Drug Sales Market Share, 2018-2029
Figure 37. China Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Natalizumab Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Natalizumab Drug Sales Market Share, 2018-2029
Figure 44. Brazil Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Natalizumab Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Natalizumab Drug Sales Market Share, 2018-2029
Figure 48. Turkey Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Natalizumab Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Natalizumab Drug Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Natalizumab Drug by Region, 2022 VS 2029
Figure 54. Natalizumab Drug Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ナタリズマブ薬の世界市場見通し2023年-2029年(Natalizumab Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

ナタリズマブ薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp